Sonoco ThermoSafe and Unilode Aviation Solutions partner on the maintenance, repair, and handling of Sonoco ThermoSafe’s passive bulk temperature-controlled containers.
This cooperation will play an important part in enabling the safe and efficient transport of pharmaceuticals and other temperature-sensitive products around the world, the two say.
Sonoco ThermoSafe’s Pegasus ULD is the world’s first FAA- and EASA-approved passive bulk temperature-controlled container for pharmaceutical use.
Engineered with composite materials, the Pegasus ULD offers a lighter solution that is substantially more damage-resistant than traditional metal containers, according to Sonoco.
The ULD is also equipped with a fully integrated, FAA-approved telemetry system, providing real-time, cloud-based data on payload and ambient temperature and key environmental factors, precisely synchronised with GPS location.
Ron Haub, segment director, Sonoco ThermoSafe, says: “Sonoco ThermoSafe is not only driving innovation in temperature-controlled container design with our Pegasus ULD, but our partnership with Unilode provides an innovative solution for the rapid expansion of preparation, handling and repair locations on a global basis.
With Unilode, we are pleased to be working with the world’s largest owner/manager of ULDs and their massive airport network, which will accelerate the adoption of the Pegasus ULD during the world’s most demanding need for pharmaceutical distribution.”
Marc Groenewegen, chief commercial officer, Unilode, says: “Unilode has stepped up its efforts to broaden its MRO customer portfolio and provide high quality maintenance and repair services to specialised ULD manufacturers and service providers in the pharmaceutical industry, in addition to its core airline market.
“We are pleased with our new agreement with Sonoco ThermoSafe that leverages Unilode’s global MRO footprint at key airports in the United States, EMEA and APAC region for repair, handling, inspection, cleaning and equipment inventory control services. This partnership will allow both companies to contribute to the global distribution efforts of the Covid-19 vaccines and other pharmaceutical products, which require temperature-controlled containers for the transport in the air cargo supply chain,” Groenewegen adds.